Epicutis offers clean, minimalist skincare formulations built around its "Skin Health" positioning and proprietary, patent-protected actives (including TSC, DSD and HYVIA®). The brand is positioned exclusively in the professional channel and is EWG Verified®, with distribution across medspas, dermatology practices and luxury spas. Epicutis has grown rapidly, reporting nearly a 100% compound annual growth rate over the past two years and more than 4,100 active professional accounts. The company traces its origins to over 20 years of bioscience research affiliated with Princeton University through Signum Biosciences. With the new growth investment from GroundForce Capital, Epicutis plans to scale brand awareness, advance its discovery pipeline, and continue expanding its professional-channel sales organization. The articles do not disclose revenue figures, founding year, or valuation.

Total raised

$38M

Funding rounds

3

Latest round

Series C

Latest activity

Jul 2026